Medicare prohibits drug 'brown bagging' in 2012

Article Overview

This article covers a Medicare fee-for-service policy update effective in 2012 that affects physician office handling and billing of drugs administered in the office setting. It explains the broader industry context, including contractor practices and private payer specialty pharmacy programs, and points readers to official CMS and payer resources for further guidance. The article is relevant to physician practices, billing staff, and compliance professionals who manage drug administration claims and office-based purchasing workflows.